Why you might consider switching
Not everyone responds the same way to a given GLP-1 medication — plateaued weight loss, persistent side effects, or simply wanting to try a dual agonist after starting on a single-pathway drug are all legitimate reasons to bring up a switch. See our glossary entries on fast responder and slow responder for how individual response variation factors into this.
How to frame the conversation
Come with specifics rather than a vague "is there something else I could try": how long you've been on the current medication and dose, what results you've seen (or haven't), and any side effects and their severity. If you've hit a weight loss plateau, say so explicitly — plateaus are common and your prescriber will have a framework for addressing them, which may or may not involve switching drugs.
Questions worth asking
- "Is my current lack of progress typical, or does it suggest this medication isn't working well for me specifically?"
- "If we switch, do we need a washout period, or can I transition directly?"
- "Will switching affect my insurance coverage or require a new prior authorization?" (Switching between drug classes, e.g., single-agonist to dual-agonist, often does.)
- "What should I expect differently in terms of side effects during the transition?"
What to keep in mind
Switching medications can reset some aspects of titration, meaning a return to lower starting doses and a new adjustment period — worth factoring into your expectations rather than assuming an immediate continuation of your prior results. It may also change your coverage status entirely; see our guide on understanding insurance coverage before assuming a switch is a simple swap.
The bottom line
A switch is a reasonable, common conversation — come prepared with your specific history and results rather than a general sense that something isn't working, and ask directly about both the clinical and coverage implications of changing.